461 related articles for article (PubMed ID: 29466965)
1. Neutropenia after intravenous immunoglobulin therapy is associated with coronary artery lesions in children with Kawasaki disease: a case control study.
Wang Z; Weng F; Li C; Shi H; Tang Z; Qiu H; He Y; Wu R; Chu M
BMC Pediatr; 2018 Feb; 18(1):76. PubMed ID: 29466965
[TBL] [Abstract][Full Text] [Related]
2. Association between maternal age and outcomes in Kawasaki disease patients.
Huang WD; Lin YT; Tsai ZY; Chang LS; Liu SF; Lin YJ; Kuo HC
Pediatr Rheumatol Online J; 2019 Jul; 17(1):46. PubMed ID: 31324255
[TBL] [Abstract][Full Text] [Related]
3. A Multicenter Study of Intravenous Immunoglobulin Non-response in Kawasaki Disease.
Wei M; Huang M; Chen S; Huang G; Huang M; Qiu D; Guo Z; Jiang J; Zhou X; Yu Q; Guo Y; Fu L; Gao W; Li F
Pediatr Cardiol; 2015 Aug; 36(6):1166-72. PubMed ID: 25812827
[TBL] [Abstract][Full Text] [Related]
4. [Clinical analysis of 942 cases of Kawasaki disease].
Zhang W; Li Q; Zhao XD; Tang XM; Wang XG; Wang M; Wu DQ; Ou Q; Yang XQ
Zhonghua Er Ke Za Zhi; 2006 May; 44(5):324-8. PubMed ID: 16780705
[TBL] [Abstract][Full Text] [Related]
5. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
Qiu H; He Y; Rong X; Ren Y; Pan L; Chu M; Wu R; Shi H
Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
[TBL] [Abstract][Full Text] [Related]
6. Reevaluation of the efficacy of intravenous gammaglobulin in the prevention and treatment of coronary artery lesion in Kawasaki disease.
Qin L; Saumu MT; Wang H; Shi H; Hu X; Cheng P
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(3):348-50, 370. PubMed ID: 16201293
[TBL] [Abstract][Full Text] [Related]
7. [Risk factors for coronary artery lesions in children with Kawasaki disease].
Li Y; Wang XM; Liu YL; Shi K; Yang YF; Guo YH
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Dec; 14(12):938-41. PubMed ID: 23234782
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
Qin LJ; Wang HW; Hu XF; Liu QJ; Shi H; Wei YX; Chen QJ; Cheng PX
Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):891-5. PubMed ID: 17254453
[TBL] [Abstract][Full Text] [Related]
9. [The mediation mechanism of coronary artery lesions in both male and female patients with Kawasaki disease].
Zhang YH; Wu RZ; Hu JY; Jin ZY; Ye ZH; Qiu HX; Chu MP; Shi HY
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Dec; 40(12):1634-1638. PubMed ID: 32062929
[No Abstract] [Full Text] [Related]
10. [Risk factors for coronary artery lesions secondary to Kawasaki disease in children].
Deng YC; Wang X; Tang XC; Huang CZ; Yang J; Mo LY
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Sep; 17(9):927-31. PubMed ID: 26412172
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting the duration of coronary artery lesions in patients with the Kawasaki disease: a retrospective cohort study.
Zhang X; He Y; Shao Y; Hang B; Xu Z; Chu M
Pediatr Rheumatol Online J; 2021 Jun; 19(1):96. PubMed ID: 34174872
[TBL] [Abstract][Full Text] [Related]
12. Elevated D-dimer level is a risk factor for coronary artery lesions accompanying intravenous immunoglobulin-unresponsive Kawasaki disease.
Masuzawa Y; Mori M; Hara T; Inaba A; Oba MS; Yokota S
Ther Apher Dial; 2015 Apr; 19(2):171-7. PubMed ID: 25257673
[TBL] [Abstract][Full Text] [Related]
13. Z-score is a possible predictor of the risk of coronary artery lesion development in patients with Kawasaki disease in Japan.
Suzuki T; Kakimoto N; Tsuchihashi T; Suenaga T; Takeuchi T; Shibuta S; Kitano N; Suzuki H
Eur J Pediatr; 2021 Sep; 180(9):2797-2805. PubMed ID: 33763715
[TBL] [Abstract][Full Text] [Related]
14. Remission of autoimmune neutropenia after development of Kawasaki disease.
Okada S; Hasegawa S; Suzuki Y; Ichimura T; Kaneyasu H; Shimomura M; Wakabayashi-Takahara M; Nakamura K; Kobayashi M; Ohga S
Pediatr Int; 2015 Oct; 57(5):1012-4. PubMed ID: 26508185
[TBL] [Abstract][Full Text] [Related]
15. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH
PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Risk of Recrudescent Fever in Children With Kawasaki Disease Treated With Intravenous Immunoglobulin and Low-Dose vs High-Dose Aspirin.
Platt B; Belarski E; Manaloor J; Ofner S; Carroll AE; John CC; Wood JB
JAMA Netw Open; 2020 Jan; 3(1):e1918565. PubMed ID: 31899532
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
Wang JR; Zhao HZ; Chang LJ; Xu X; Gao Y; Li M; Kong QY; Wang MM; Zhao CF
Eur J Pediatr; 2023 Oct; 182(10):4399-4406. PubMed ID: 37480545
[TBL] [Abstract][Full Text] [Related]
18. Coronary artery lesion risk and mediating mechanism in children with complete and incomplete Kawasaki disease.
Shi H; Qiu H; Jin Z; Li C; Yang X; Huang C; Wu R; Zhuang G; Chu M
J Investig Med; 2019 Aug; 67(6):950-956. PubMed ID: 30804174
[TBL] [Abstract][Full Text] [Related]
19. Coronary artery lesions and the increasing incidence of Kawasaki disease resistant to initial immunoglobulin.
Kibata T; Suzuki Y; Hasegawa S; Matsushige T; Kusuda T; Hoshide M; Takahashi K; Okada S; Wakiguchi H; Moriwake T; Uchida M; Ohbuchi N; Iwai T; Hasegawa M; Ichihara K; Yashiro M; Makino N; Nakamura Y; Ohga S
Int J Cardiol; 2016 Jul; 214():209-15. PubMed ID: 27070994
[TBL] [Abstract][Full Text] [Related]
20. Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.
Chen J; Liu P; Hu W; Xu Y; Deng J
Clin Rheumatol; 2021 Oct; 40(10):4191-4197. PubMed ID: 34059986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
